LUMINANCE: Results support use of durvalumab and platinum-etoposide for extensive stage SCLC
LUMINANCE: Results support use of durvalumab and platinum-etoposide for extensive stage SCLC
CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC
Latest treatments in oesophageal cancer
Final data from phase II study of eftilagimod alpha and pembro in PD-1/PD-L1 inhibitors resistant second line metastatic NSCLC
Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC
Tumour markers and their role in cancer treatment
Special populations underrepresented in oncology
PET CT for early-stage malignancies in the Philippines
Lung cancer screening and treatment in the Philippines
The role of curative neoadjuvant treatment in certain cancer types
The pros and cons of breast IORT and ultra hypofractionation (FR)
War in Ukraine: The logistical challenges of transferring medical materials